Related Experiment Video
Updated: Jun 10, 2026
09:38
Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery
Published on: April 14, 2016
Tapentadol: an initial analysis
1Department of Hematology/Oncology/Palliative Care, Mayo Clinic, Phoenix, Arizona, USA.
Journal of Opioid Management
|July 21, 2010
Summary
Tapentadol hydrochloride is a novel analgesic with dual action, offering potential for neuropathic pain management. Clinical trials show it has less potency than some opioids but minimal drug interactions.
Area of Science:
- Pharmacology
- Pain Management
- Neuroscience
Background:
- Tapentadol hydrochloride is a novel analgesic with a dual mechanism of action.
- It acts as a mu-opioid receptor agonist and a norepinephrine reuptake inhibitor.
- This dual action offers potential for synergistic analgesic effects and reduced opioid escalation.
Purpose of the Study:
- To evaluate the analgesic properties of tapentadol hydrochloride.
- To assess its potential in managing neuropathic pain.
- To investigate its pharmacokinetic profile and drug interaction potential.
Main Methods:
- Preclinical studies in acute and neuropathic pain models.
- Human clinical trials in patients with nonmalignant pain.
- Assessment of CYP 450 interactions.
Main Results:
- Preclinical models confirmed analgesic properties in acute and neuropathic pain, though with lower potency than morphine.
- Human trials indicated less potency than a step-3 opioid in nonmalignant pain.
- Tapentadol demonstrated minimal CYP 450 interactions, suggesting a low potential for drug-drug interactions.
Conclusions:
- Tapentadol hydrochloride presents a novel dual-action analgesic mechanism.
- It shows promise for neuropathic pain management, with a favorable drug interaction profile.
- Further clinical trials are needed to establish its efficacy in cancer pain and neuropathic pain populations.
Related Concept Videos
01:25Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...